A decade earlier, Elefant, who was blind, had created a New York tandem
cycling program with Achilles International, which helps people with disabilities join running events.
After a quick lunch stop in Tekapo we start
our cycle program with a quiet ride alongside a canal system with spectacular views of Mt Cook & the Southern Alps.
Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations
with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant
cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination
with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed
with the U.S. Securities and Exchange Commission (the SEC).
Her viewpoints on the show are likely to gain scrutiny as viewers watch whether she gels
with the
program's other co-hosts, who typically maintain a more liberal perspective on the news
cycle.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated
with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated
with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE
program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances
with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated
with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life
cycles that characterize the wireless communications industry.
Unlike other lead generation companies that might only provide lead generation outsourcing (many through international representatives), we provide U.S. based turnkey
programs to cover every step of the sales
cycle,
with B2B lead generation services and support for qualifying business leads based on sound marketing principles.
Against that background, one might justifiably ask whether it makes sense to have one economy (the United States) in a tightening monetary policy
cycle, while the other (eurozone) presses on
with its more accommodative easing
program.
We have helped companies
with programs targeted at helping them improve execution throughout the Client Life
Cycle.
Fox News set a record earlier in the month
with 24 million people tuning in to the first Republican primary debate of the 2016 election
cycle, making it the most - watched cable telecast of all time, excluding sports
programming.
The underlying assumption behind all the models in this chapter is that a congregation has an exciting possibility and responsibility to create a comprehensive marriage and family nurture
program, beginning
with remote preparation for marriage and extending through all the changing seasons of the life
cycle of a family.
An anti-doping group is saying they have «insurmountable» evidence of Armstrong's involvement
with a very sophisticated doping
program during his
cycling career.
The Initiative funded a number of
programs such as: the Soil Not Oil International Conference, the Story of Soil video, and the Carbon Farming Tour to San Francisco Bay Area farms
with the Carbon
Cycle Institute.
This research stream, which is primarily conducted within ARS's National
Program on Quality and Utilization of Agricultural Products, is reviewed / renewed in five - year
cycles,
with the next
cycle starting in 2015.
With the addition of Oregon, NICA now has the infrastructure in place to serve just over 60 % of the country's population; we are well on our way towards fulfilling our mission of providing every American teenager the opportunity to participate in NICA
programming through a school or community based
cycling team.»
Minnesota convinced so many kids who would have had spots at more successful
programs later in the
cycle to instead stick
with them and sign early.
Due to the fact that our diffuser is extremely powerful and diffuses only pure essential oils, we have
programmed our device
with a «Usage
Cycle» built into the unit.
GOOD + Foundation ™ partners
with a national network of leading
programs to break the
cycle of family poverty through the power of donated goods and services.
We do not have statistics specifically for the health of infants from our own
programs, but the published reports have suggested that frozen embryo transfer
cycles in general are associated
with reduced risks of low birthweight, very low birthweight, small for gestational age, pre-term birth, antepartum hemorrhage, placental abruption, perinatal mortality, and pre-eclampsia.
Program washer to the longest wash
cycle (heavy duty)
with hot water wash.
This off - off - year election
cycle presents the perfect opportunity to pilot such a
program in at least VA and NJ, and in doing so, train the first set of new digital organizers
with whom to rebuild the bench.
We urge the Administration and legislature to work
with business and other stakeholders to develop this
program during the current budget adoption
cycle.
Bicycle Sundays, a Westchester County Parks
program, is sponsored by Con Edison, New York Presbyterian Hospital, the Westchester Parks Foundation and Danny's
Cycles,
with support from WHUD.
``...
with regards to the sales transactions on the market daily, weekly, monthly or annually as the
program involves continuous sales, a
cycle of sales and re-stock until one decides to quit or terminate the
cycle.»
«After last year's incredibly successful Participatory Budgeting process in the 38th District,
with the highest number of participants in the City, it is my pleasure to re-launch this
program for the coming budget
cycle!»
We have made a major breakthrough to end this
cycle of failure by partnering
with Catholic Charities, Buffalo Public Schools and the Say Yes
program.
During the application
cycle for the 2018 - 19 fellowship year, we are hosting a series of live chats
with fellows in various disciplines and career stages to share their insights and answer your questions about the
program.
The University of Michigan
Program in Biomedical Sciences will stop requesting GRE scores starting
with next year's admission
cycle
Some of the new nuclear science research
programs, including the one at MIT, are studying new reactor designs and fuel
cycles that scientists (and policy - makers) hope will make nuclear plants safer and cheaper to operate, and produce waste materials
with smaller volume, shorter half - lives, and less appeal to terrorists and other would - be nuclear powers.
The budget
cycle begins
with the president's annual budget proposal outlining White House spending requests for each federal agency and
program.
Researchers from the Perelman School of Medicine at the University of Pennsylvania, in partnership
with ORGANIZE — a non-for-profit organization based in New York which leverages health data to end the organ donor shortage by applying smarter technologies, utilizing social media, building more creative partnerships, and advocating for data - driven policies — The Bridgespan Group — a global nonprofit organization that collaborates
with mission - driven leaders, organizations, and philanthropists to break
cycles of poverty and dramatically improve the quality of life for those in need — and Gift of Life Donor
Program — an OPO which serves the eastern half of Pennsylvania, southern New Jersey, and Delaware — evaluated the metrics and criteria used to measure OPOs across the country, and found significant discrepancies in how potential donors are evaluated and identified.
In the new study, Narula, Igoshin and collaborators set out to explain how B. subtilis times its sporulation decision
with its cell - division
cycle, a
programmed series of events that cells normally follow to reproduce.
Whatever the outcome of the first doping case stemming from the passport
program,
cycling has at least begun to restore its credibility
with the anti-doping movement — WADA has been fiercely critical of the UCI's efforts in the past.
«
With modest success in the technology management program, these cycles could compete with combined - cycle natural gas turbines and carbon capture and storage,» Dennis s
With modest success in the technology management
program, these
cycles could compete
with combined - cycle natural gas turbines and carbon capture and storage,» Dennis s
with combined -
cycle natural gas turbines and carbon capture and storage,» Dennis said.
Study authors suggest that breaking the
cycle of transmission of drug - resistant TB requires a greater focus on infection control efforts — while also maintaining global
programs to quickly detect and effectively treat all people
with TB.
From 1990 to the formation of NEI in 1994 he was the Vice President of Technical
Programs at the U.S. Council for Energy Awareness (USCEA) where he was responsible for ensuring the technical accuracy and effectiveness of USCEA's industry communications and also led the regulatory, policy and R&D activities associated
with supporting companies in the front - end of the nuclear fuel
cycle.
Met mRNA was expressed rhythmically during the reproductive
cycle,
with peak mRNA accumulation just prior period of oocytes
programming of sex.
Altieri and his team are currently focused on three
programs to understand the biology of survivin
with respect to cell
cycle progression, in particular, mitosis, cell survival and the cellular stress response and how exploiting these pathways may provide new cancer therapeutics.
This is in accordance
with previous reports that decitabine and 5 - azacytidine produce a marked synergistic effect in combination
with suberoylanilide hydroxamic acid and romidepsin in T - lymphoma cell lines by modulating cell
cycle arrest and apoptosis.26, 27 As a mechanism of action, KMT2D mutations of B - lymphoma cells promote malignant outgrowth by perturbing methylation of H3K4 that affect the JAK - STAT, Toll - like receptor, or B - cell receptor pathway.28, 29 Here our study indicated that dual treatment
with chidamide and decitabine enhanced the interaction of KMT2D
with the transcription factor PU.1, thereby inactivating the H3K4me - associated signaling pathway MAPK, which is constitutively activated in T - cell lymphoma.13, 30,31 The transcription factor PU.1 is involved in the development of all hematopoietic lineages32 and regulates lymphoid cell growth and transformation.33 Aberrant PU.1 expression promotes acute myeloid leukemia and is related to the pathogenesis of multiple myeloma via the MAPK pathway.34, 35 On the other hand, PU.1 is also shown to interact
with chromatin remodeler and DNA methyltransferease to control hematopoiesis and suppress leukemia.36 Our data thus suggested that the combined action of chidamide and decitabine may interfere
with the differentiation and / or viability of PTCL - NOS through a PU.1 - dependent gene expression
program.
The Institute's Hubble Mission Office has initiated a pilot, ultra-low priority SNAP
program (14840, PI: Bellini) in
Cycle 24,
with the goal of taking useful data in Hubble orbits that absolutely no other
program is able to use.
As part of a Head in the Clouds
program with AWS,
Cycle Computing, and Intel, NASA is leveraging cloud computing to study the carbon stored in trees and bushes over the Sahara.
In my #aabikinibody
program, we help women get off the harmful, restrictive binge
cycle and find a balance
with eating.
A group of sport scientists from Baylor University recently did a study on 20 students
with solid weight training experience and made them follow an identical lifting
program for 4 weeks, followed by a two - week layoff, after which they went through another four - week training
cycle.
With the RPT
program outlined above, enough calories to sustain muscle growth, and the
cycling of carbohydrates, you have the tools needed for sizable strength gains.
In Moon Club, our monthly guided ritual
program to help you sync
with the moon's
cycles and supercharge your life, we took the time to chat
with feminist venture capitalist Kimmy Scotti, who reminded us of the entrepreneurial power we have to shift the whole collective by thinking BIG and BOLD.
Circle + Bloom Natural
Cycle for Fertility Mind - Body
Program is an effective tool to help you take an active role in reducing the anxiety and stress associated
with dealing
with a fertility health issue, undergoing a fertility treatment and trying to get pregnant.
You were, prior to undertaking the Flo Living
program, on medications for acne and
cycle issues — what has been your journey
with this?
Whichever
program you choose, follow it up
with intensive sprinting,
cycling, rowing.
A well structured
program with varied
cycles and a long term plan will help you get the results you are hoping to achieve
The Ayurvedic Woman is a 3 Part
Program that enables you
with the power of Ayurvedic Knowledge to experience symtom - free health
with a smooth menstrual
cycle and a painless, graceful transition through menopause.
Holistic Natural Residential Weight Loss
Programs for permanent weight loss consisting of improving eating, sleeping and exercise habits
with regular schedules, addressing the underlying emotional issues, such as self - esteem, loneliness and boredom, restoring the natural hormonal hunger satiety
cycle, and educating patients about shopping and food preparation.